A rat blood pressure assay was used to perform a structure-activity relationship study (SAR) of Leu-Val-Val-hemorphin-7 (LVV-H7), a fragment of
hemoglobin (Hb) beta-chain, elucidate the mechanisms of its cardiovascular effects, and test its potential involvement in the pressor activity of
diaspirin crosslinked Hb (
DCLHb), a recently developed Hb-based
oxygen carrier. The SAR study revealed that the C-terminal-Arg-Phe-amino acid sequence of
LVV-H7 contained the main determinants of the pressor activity of this
peptide. Drug interaction studies using various inhibitory drugs (e.g.,
phentolamine,
clonidine, etc.) and
LVV-H7 showed that the pressor effect and
tachycardia elicited by
LVV-H7 involved the activation of the sympathetic nervous system (SNS). Additional studies using
phenytoin (sodium channel blocker), [Tic7]H7(5-7)-NH2 (putative antagonist of receptors for LVV-H7) and H7(5-7)-NH2, an amidated C-terminal fragment of
LVV-H7, suggested that
LVV-H7 activated the SNS by interacting with specific receptors functionally coupled with
phenytoin-sensitive
sodium channels. The pressor effect and
tachycardia caused by
LVV-H7 were potentiated by
captopril, suggesting that the
angiotensin converting enzyme may contribute to the inactivation of
LVV-H7 in rats. The pressor activity of
DCLHb, in contrast to that elicited by
LVV-H7, was not affected by animal pretreatment with
LVV-H7 fragments shown to inhibit the pressor effect of
LVV-H7. We conclude that: 1) LVV-H7 is unlikely to mediate the pressor activity of
DCLHb in rats; 2) the pressor and tachycardic activities of LVV-H7 are mediated by the SNS; 3) the C-terminal-Arg-Phe-amino acid sequence of LVV-H7 contains the chemical groups responsible for the pressor effect of this
peptide in rats; 4) LVV-H7 and
FMRF amide-related
peptides may share the same mechanism of pressor activity in rats.